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Staging Urinary B ladder Cancer
after Transurethral B iopsy: Value o f F a st
Dynamic C ontrast-enhanced MR Im aging1
PURPOSE: To evaluate contrast en­
hancement patterns of urinary bladder 
cancer and surrounding structures and 
to evaluate a fast dynamic first-pass 
magnetic resonance (MR) imaging 
technique in tumor and node staging 
and in differentiation of urinary b lad­
der cancer from postbiopsy effects*
MATERIALS AND METHODS:
Sixty-one consecutive patients with 
histologically proved urinary bladder 
cancer were referred to undergo un ­
enhanced and dynamic MR imaging 
1-4 weeks after transurethral resec­
tion or biopsy. Subtraction and time 
(to beginning of enhancement) im­
ages were acquired.
RESULTS: Results with unenhanced 
Tl- and T2-weighted images were 
compared with those obtained with 
the unenhanced images plus dynamic 
contrast material-enhanced single­
section turbo fast low-angle shot 
(FLASH) images. Urinary bladder 
cancer started to enhance 6.5 sec­
onds ±3.5 (standard deviation) after 
the beginning of arterial enhance­
ment, which was 4 seconds earlier 
than most other structures (postbiopsy 
tissue, 13.6 seconds ± 4.2). In differ­
entiation of postbiopsy tissue from 
malignancy on the basis of the begin­
ning of enhancement depicted on 
time and subtracted images, accuracy 
improved from 79% to 90% (P < .02) 
and specificity improved from 33% to 
92% (not significant). Overall, tumor 
staging accuracy improved signifi­
cantly from 67% to 84% (P < .01) by 
adding the turbo FLASH images.
CONCLUSION: Fast dynamic first- 
pass MR imaging, with at least one 
image acquired every 2 seconds, im­
proved delineation of urinary bladder 
cancer, tumor staging, and detection 
of metastases.
Ca r c in o m a  of the urinary bladder is one of the most common ma­
lignant tumors of the urinary tract in 
male and  female patients. Its treat­
m ent and prognosis are largely deter­
mined by the depth of tum or infiltra­
tion and the extent of metastases (1). 
Therefore, exact staging is mandatory. 
As clinical staging is not reliable for 
deeply infiltrative tumors, more accu­
rate m ethods are needed. Com puted 
tom ography (CT) is a valuable tool, 
bu t m any reports have shown the su­
periority of magnetic resonance (MR) 
imaging for the evaluation of urinary 
bladder cancer (2^10). Although MR 
imaging is better than CT for staging 
urinary bladder cancer, CT is more 
commonly used in most centers be­
cause of its greater availability and of 
the greater familiarity with this tech­
nique. Recently, several authors have 
described the use of gadolinium-en­
hanced MR imaging for staging uri­
nary bladder cancer (10,11-14). With 
intravenously administered gadopen- 
tetate dimeglumine, visualization of 
small tumors improved (10,12-14) and 
increased accuracy of local staging 
was reported (11,14). The best stag­
ing results w ith contrast material- 
enhanced MR were obtained with 
fast T l-w eighted imaging (9).
Most patients are referred for MR 
staging following transurethral resec­
tion (TUR), w ith histologically proved 
invasion of the muscle layers of the
bladder wall. Even w hen gadolinium 
enhancem ent is used, however, dif­
ferentiation betw een residual tumor 
and  edema, scar, or granulation tissue 
remains problematic in patients after 
TUR (12,14-17).
Fast MR imaging, w ith at least two 
images acquired every second, depicts 
the first pass of the bolus of contrast 
material, w hich has resulted in im­
proved differentiation betw een be­
nign and malignant lesions of the 
breast and  musculoskeletal system 
(18,19). The purpose of this study was 
to evaluate the enhancem ent patterns 
of urinary bladder cancer and its sur­
round ing  structures. We also assessed 
the value of fast MR imaging during 
the first pass of the bolus of contrast 
material to help differentiate residual 
tumor from postbiopsy effects, stage 
tumors, and  detect node metastases,
MATERIALS AND METHODS
In this prospective study, 61 consecu­
tive patients (47 m en and 14 w om en, aged  
38-82 years [mean, 61 years]) w ith histo­
logically proved urinary bladder cancer 
w ere referred to undergo MR imaging  
w ithin  1-4 w eeks after TUR or biopsy.
Tw o of these patients had undergone n eo ­
adjuvant chem otherapy, and they had 
also undergone MR im aging examination  
before chem otherapy. Fifty-seven of the 
61 patients w ere scheduled subsequently  
to undergo curative (n = 42) or palliative 
salvage (n = 15) cystectomy, because they
Index terms: Bladder neoplasms, 83.32 • Bladder neoplasms, MR, 83,121416, 83.12143 • Bladder 
neoplasms, staging, 83.32 • Gadolinium • Glucagon • Magnetic resonance (MR), treatment plan­
ning, 83.12143
Abbreviations: FLASH — fast low-angle shot, MP-RAGE = magnetization-prepared rapid gradient 
echo, SI = signal intensity, TUR = transurethral resection.
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Figure 1. Well-differentiated transition cell carcinoma of the bladder/ stage T4a, with poorly differentiated metastasis in the right iliac lymph 
node, (a) Unenhanced Tl-weighted three-dimensional MP-RAGE image shows urinary bladder cancer (long arrows), with dilatation of the left 
ureter (short arrows) and erilarged lymph node (curved arrow), (b) Subtracted image obtained 6.25 seconds after the start of arterial enhance­
ment shows beginning node (curved arrow) and tumor (straight arrows) enhancement, (c) In time image, each color represents 1.25 second. 
Node enhancement starts at 2.5 seconds, and tumor enhancement starts at 6,25 seconds. Straight arrows indicate urinary bladder cancer; 
curved arrow indicates enlarged lymph node, (d) In the slope image, maximal slope of enhancement is color coded. Although the center of the 
tumor shows higher slope value (arrows), tumor cannot be delineated on the basis of this image, (e) Maximal SI image (at 45 seconds) shows 
more enhancement of tumor (straight arrows) and node metastasis (curved arrow), (f) Histologic section with vascular stain of enlarged lymph 
node shows more pathologic vessels (brown structures [arrows]) in the metastatic part of the node than in normal lymphatic tissue. Metastatic 
area (M) is surrounded by pathologic vessels. Node metastases were poorly differentiated transition cell carcinoma, whereas primary bladder 
tumor consisted of well-differentiated transition cell carcinoma with less neovascularization. (Q-bend stain; original magnification, x 30.)
had either a highly malignant (grade 3) 
superficial tumor or an invasive tumor 
found at TUR or biopsy. The remaining  
four patients were under going 1-year fol­
low-up TUR.
MR imaging was performed at 1.5 T 
(Magnetom 63/84 SP 4000; Siem ens M edi­
cal Systems, Erlangen, Germany), with use  
of a Helmholtz double-surface coil. To re­
duce bowel motion, 0.5 m l  glucagon was 
administered intravenously before the exam- 
ination, and 1.5 mL glucagon was adm in­
istered intravenously during the examina­
tion, by means of a drip infusion. To reduce 
respiratory movements, an adjustable belt 
was wrapped around the patient's abdo­
men, to cause slight compression.
Initially, three-dimensional T l-w eigh ted  
magnetization-prepared rapid gradient
echo (MP-RAGE) imaging was performed 
(repetition time m sec/echo time m sec/in­
version time msec — 10/4/500,10° flip angle, 
1.2-mm effective section thickness, 192 X 
256 matrix, 300-mm field of view , tw o sig­
nals acquired, 9-minute acquisition time). 
The ordering of the phase-encoding steps 
in k space was sequential.
Multiplanar reconstruction was performed 
w ith the MP-RAGE data, to obtain the 
plane in which the tumor and, eventually, 
the pelvic lym ph nodes were optimally vis­
ible. In this plane and in the axial or sagittal 
planes in the first 10 patients, a T2rweighted 
spin-echo image was acquired (2,000/ 100, 
192 x  256 matrix, 300-mm field of view, 
8-mm section thickness, 2-mm intersection  
gap, tw o signals acquired). In the remain­
ing 51 patients a fast spin-echo image was
acquired (3,000/90 [effective], 12 echo trains, 
320 x 512 matrix, 300-mm field of view, 
8-m m  section thickness, 2rmm intersection 
gap, three signals acquired). During intra­
venous bolus injection of gadopentetate 
dimeglumine (Magnevist; Schering, Ber­
lin, Germany) (0.1 mmol per kilogram of 
body weight) in the section in which the 
tumor and, if present, enlarged lymph  
nodes were optimally visualized, 60 im­
ages were acquired with a magnetization- 
prepared single-section turbo fast low- 
angle-shot (turbo FLASH) sequence (7/3/ 
15,10° ilip angle, 128 x 256 matrix, 350-mm 
field of view, 8-mm section thickness), with 
one image obtained every 2.5 seconds in 
25 cases (two signals acquired) and one 
image obtained every 1.25 second in the 
remaining 36 cases (one signal acquired).
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Figure 2. Time (T) of lesion enhancement after the start of arterial enhancement. Solid box = 
cancer, open box = postbiopsy tissue.
To determine enhancement patterns of 
iliac or femoral arteries, bladder wall, and 
tumor, time-signal intensity (SI) curves were 
made in operator-defined regions of interest. 
To quantify maximal tumor enhancement, 
a tumor-to-bladder wall enhancement 
ratio was determined with the follow-
ing formula. (ASI|e¡J¡on ASIbiacjder wall) ’T"
^^ bladder wall/ ^ l^esion and S^Iblndder wall
being the difference in SI at maximal en­
hancement, which occurs 45 seconds after 
the onset of arterial enhancement in the 
lesion and normal bladder wall, respectively.
The dynamic single-section images were 
transferred to a workstation (Hewlett- 
Packard, Palo Alto, Calif). With software 
written by one of the authors (N.K.), sub­
traction turbo FLASH images, color-coded 
time and slope images, and maximal SI 
images were calculated (Fig 1) (the soft­
ware is available on request). In time im­
ages, the beginning of enhancement of 
tumor and other tissues in relation to the 
beginning of arterial enhancement is color 
coded and projected over the unenhanced 
image. The beginning of enhancement is 
defined as an increase of 10 arbitrary units 
above baseline noise. In the slope image, 
the slope of maximal SI increase is color 
coded. The maximal SI images display 
maximal enhancement 45 seconds after 
the beginning of arterial enhancement.
The subtraction technique is commercially 
available on most MR imaging systems.
The images were interpreted prospec- 
tively by two investigators (J.O.B., G.J.J.), 
who were not acquainted with the clinical 
and surgical results, except that prior bi­
opsy had revealed carcinoma. The location 
of the tumor and biopsy site were un­
known to them. On subtraction and time 
images, the onset of enhancement after 
arterial enhancement was registered. On 
slope images and maximal SI images, the 
slope of the maximal enhancement rate 
and maximal final enhancement were 
evaluated for the tumor and other struc­
tures such as postbiopsy lesion, normal 
bladder wall, bowel loops, prostate or 
uterus, bone marrow, and muscle. On the 
slope images, a lesion was considered ma-
lign an tif the slope value was higher in the 
tumor than in surrounding structures.
O n the basis of earlier experience (20) 
w ith time images, a lesion w as considered  
m alignant if enhancem ent started within  
10 seconds after the beginning of arterial 
enhancem ent. A lesion was considered  
benign (eg, postbiopsy tissue) if enhance­
m ent started later. With these criteria, dif-
r "
ferentiation betw een  tumor and postbi­
opsy tissue with unenhanced im aging was 
compared with differentiation w ith un en­
hanced plus turbo FLASH imaging. Also, 
staging results were evaluated w ith both  
sets of images. Staging was performed ac­
cording to the TNM system  (21). Local tu­
mor staging w as performed on the basis of 
the criteria of Fisher et al (2). N ode staging  
was performed as described by Barentsz et 
al (22): To determine node size, the maxi­
mal long-axis and axial size w ere m ea­
sured, Axial size w as defined in a plane  
perpendicular to the long axis through  
the thickest part of the node. From these 
measurements, an index was calculated as 
the shortest axial size divided by the long  
axis. Lymph nodes were considered to be 
pathologically enlarged w h en  the index  
was more than 0.8 (a round node), with  
a shortest axial size of 8 mm or more, or 
w h en  the index was less than 0 .8, w ith  a 
shortest axial size of 10 mm or more. An 
asymmetric cluster of small lym ph nodes  
was also considered pathologic,
Findings in all patients were confirmed 
at histologic examination. Im aging results 
were correlated w ith histopathologic find­
ings after cystectom y (n =  57) or with the 
findings at repeated TUR (n =  4). O n the 
basis of findings on the MR images, speci­
men sectioning for pathologic examina­
tion was performed by the pathologist 
(H.P.) with one of the radiologists (J.O.B.). 
Specimen sectioning was performed in the 
plane in w hich the turbo FLASH image 
was obtained.
RESULTS
There were no differences between 
the two observers in determ ining the
beginning of lesion enhancement. 
Figure 2 depicts the beginning of le­
sion enhancem ent in relation to the 
start of enhancem ent of the iliac or 
femoral artery. In 12 patients, no re­
sidual malignancy was present after 
TUR perform ed before MR imaging. 
In these cases, a lesion was visible on 
the unenhanced  images. In 11 of the 
cases, enhancement began more than
10 seconds after arterial enhancement 
(Fig 3). In 47 of the remaining 49 cases, 
the bladder cancer could be visualized 
on the single-section dynamic image. 
In two cases, no tumor was visible on 
the three-dimensional MP-RAGE im­
ages, which resulted in incorrect sec­
tion acquisition in the FLASH image. 
Findings in these cases were recorded 
as false negative. In 44 of the remaining 
47 cases, the urinary bladder cancer 
started to enhance within 10 seconds 
after the artery (mean, 6.5 seconds ± 
3.5 [standard deviation]). Postbiopsy 
tissue started to enhance 13.6 seconds ±
4.2 after arterial enhancement. These 
differences between urinary bladder 
cancer and postbiopsy tissue are sig­
nificant (P < .0001, two-tailed P value).
Results of differentiating postbi­
opsy effects from malignancy with 
and w ithout the dynamic FLASH im­
ages, with a threshold of 10 seconds, 
are presented in Table 1. The only 
false-positive result occurred in the 
case of a patient with early lesion en­
hancem ent after 5.0 seconds. Findings 
at histologic examination revealed 
granulation tissue with hyperemia. 
The five false-negative cases included 
two patients in whom the wrong sec­
tion was imaged, two w ith  superficial 
bladder cancer, and one in whom the 
lesion consisted predominantly of 
postbiopsy tissue with one micro­
scopic area of residual tum or (Fig 4).
In all cases, maximal SI of all struc­
tures was reached within 45 seconds 
after the start of arterial enhance­
ment. Maximal lesion enhancem ent 
values in relation to wall enhance­
m ent ([ASI[esi0n ASIbiadder wall] “
A S  l a d d e r  w ail)  showed considerable 
overlap betw een cancer and postbi­
opsy effects. With the slope images, 
differentiation between benign and 
malignant lesions was impossible. In 
only 16 of 61 patients could the m a­
lignant nature of the lesion be recog­
nized on the basis of the higher slope 
value on these images.
Enhancement of the following struc­
tures was seen before the 10-second 
threshold: bowel loops in  12 of 61 
cases (Fig 5d), bone m arrow  in six, 
muscle in three, uterus and parame- 
trial tissue in two, and benign pros­
tatic hypertrophy in three. In all of
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Figure 3. Granulation tissue after TUR. (a) Tl-weighted image shows 
mass (arrows), (b) On subtraction image obtained 15 seconds after the 
start of arterial enhancement, no mass enhancement is present, which 
is evidence of postbiopsy tissue, (c) Findings at pathologic examina­
tion confirmed granulation tissue (arrows). A = anterior, P «= poste­
rior, C = cranial. Ruler indicates centimeters.
T able 1
Differentiation between Tumor and 
Postbiopsy Tissue _ _ _ _ _ _ _ _
: Histologic Stage 
after Cystectomy
Finding No Tum or T um or Total
►
U nenhanced  T l-  an d  
T2-w eighted  Imaging*
N o  tum or
Tum or
Total
4 5 9 
8 44 52 
12 49 61
U n en h an ced  T l-  an d  
T2-w eighted  an d  
D ynam ic Imaging*
N o tumor 
Tum or 
Total
1 45
* Accuracy, 
33%; positive 
predictive vat 
+ Accuracy, 
92%; positive 
predictive val
* * > r * , •, * ‘ • », 
79%; sensitivity, 90%; specificity, 
predictive value, 87%; negative 
ue, 44%.
90%; sensitivity, 90%; specificity, 
predictive value, 98%; negative 
ue, 69
these cases, however, urinary bladder 
cancer showed earlier enhancement. 
These structures could be separated 
from bladder cancer on the unen ­
hanced images on the basis of their 
location and morphology.
There was disagreement in tum or 
staging between the two observers in 
three cases, One observer judged dis­
ease of a lower stage in one case; the 
other observer judged disease of a 
higher and lower stage in one case 
each, The interobserver variation was 
therefore 5%. The results presented  in 
Tables 1-3 represent the data for bo th  
observers. In cases of disagreement, 
the diagnosis was decided by consen­
sus. Results of tumor staging are p re­
sented in Table 2, The additional use 
of the dynamic FLASH images im­
proved overall staging results signifi­
cantly, from 67% to 84% (P < .01, 
McNemar test). Better accuracy was 
mainly due to better differentiation 
between postbiopsy tissue and malig­
nancy (n = 7) and to better recogni­
tion of extravesical tum or extension 
(n = 4) (Fig 5). There was no differ­
ence in staging accuracy in patients 
who underw ent imaging 1 w eek ver­
sus 4 weeks after TUR. In five patients, 
postbiopsy hemorrhage was present 
that could be differentiated from tu ­
mor by its lack of contrast enhance­
ment.
There was disagreement betw een 
the observers in  node staging in one 
case. One of the observers considered 
a marginally enlarged node to be 
negative. Table 3 presents the results 
of node staging. In 11 cases, the Tl-
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weighted MP-RAGE images correctly 
showed enlarged lymph nodes. In 
one case this enlargement was caused 
by reactive enlargement with atypical 
cells; in the other 10 cases node en­
largement was caused by métastasés. 
In the remaining 46 cases, the three- 
dimensional MP-RAGE image cor­
rectly showed normal-size lymph 
nodes, but microscopic métastasés 
were missed in four cases.
Enlarged lymph nodes in 11 pa­
tients and normal-size lymph nodes 
in nine patients could be included in 
the dynamic FLASH single section 
together with the bladder tumor. En­
larged nodes in 11 patients and nor­
mal-size nodes in three patients 
showed contrast enhancement that 
was as early as (n ~ 9) or earlier than 
(n = 5) enhancement in the tumor in 
the urinary bladder (Fig 1). In one pa­
tient w ith an enlarged node without 
metastases and in one patient with a 
normal-size lymph node, early en­
hancement was false positive. Early 
enhancement in two patients permit­
ted metastases in normal-size lymph 
nodes to be recognized (Fig 6). Histo­
logic examination of specimens ob­
tained in the remaining six patients 
with late or unenhancing normal-size 
nodes did not reveal metastases.
DISCUSSION
Superficial bladder cancer (eg, w ith­
out muscular invasion) is found in 
two-thirds of all patients with bladder 
tumors. Superficial bladder cancer can 
be treated with local endoscopic re­
section with or without adjuvant in­
travesical installations of chemothera­
peutic agents. Further staging is not
October 1996
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Figure 4. Granulation tissue after TUR in a patient with one microscopic area of residual transition cell carcinoma in the muscle layer (stage 
T2). (a) T1-weighted image shows slight thickening of the bladder wall near the left ostium (arrows), (b) Subtraction image obtained 15 seconds 
after the start of arterial enhancement shows no tumor enhancement, (c) Findings at histologic examination revealed predominantly granula­
tion tissue and fibrosis, with one microscopic area of residual tumor (arrows). (Hematoxylin-eosin stain; original magnification, X 20.)
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necessary in this group, because the 
distinction of superficial from invasive 
tumors can be made at TUR or biopsy. 
This is an integral part of clinical stag­
ing. In patients with invasive tumors, 
staging is necessary to select treatment 
with curative cystectomy versus pallia­
tive chemotherapy or radiation ther­
apy. The best staging technique in this 
group of patients is MR imaging (10).
Patients referred for MR imaging 
have often undergone TUR or biopsy. 
Staging with MR imaging after TUR 
has been shown to be problematic, as 
differentiation between tum or and 
edema and granulation or scar tissue 
on T2-weighted images is limited. Dif­
ferentiation remains impossible even 
with gadolinium-enhanced imaging 
(12,14-17).
Figure 5. Transition cell carcinoma with pros­
tatic invasion (stage T4a). (a) Tl-weighted  
MP-RAGE image and (b) T2-weighted fast 
spin-echo image show no tumor. On (c) sub­
traction image obtained 5.0 seconds after the 
start of arterial enhancement and (d) time 
image, early enhancement at 5.0 seconds in 
prostate (arrows) is visible, which is evidence 
of stage T4a urinary bladder cancer. In d, 
each color represents 1.25 second. Note early 
enhancement of rectum and sigmoid colon. 
Bowel enhancement starts at 6.25 seconds and 
can be differentiated from respiration motion 
of the cranioventral part of the abdominal 
wall. Motion artifacts show random distribu­
tion of multiple colors, including green-white, 
(e) Findings at histologic examination con­
firmed urinary bladder cancer with invasion 
in prostatic tubules (arrows). (Hematoxylin- 
eosin stain; original magnification, x  20.)
D uring the first pass of the bolus 
of contrast material, the difference in 
concentration betw een the intra- and  
extravascular com ponent is maximal. 
In this phase, transportation of con­
trast material from the vessels into the 
tissues occurs rapidly, and  more rap ­
idly in lesions w ith  neovasculariza-
Volume 201 • Number 1 r/
Radiology ♦ 189
tion (23) such as urinary bladder and 
breast carcinoma (18,24,25). Therefore, 
these lesions show earlier enhance­
m ent compared with tissues w ithout 
neovascularization. After about 30-45 
seconds, an equilibrium phase, or max- 
imal-enhancement phase, is reached 
in which the difference in contrast 
material concentration in the intra- 
and extravascular space decreases. 
Images obtained 45 seconds after the 
beginning of arterial enhancem ent 
display the maximal SI, because at this 
time in all patients bo th  urinary blad­
der and mass have reached their maxi­
mal SI, which persists for at least sev­
eral minutes (Fig 7 [plateau phase]).
Conventional gadolinium-en­
hanced MR images depict enhance­
ment in this plateau phase, w hen  the 
difference in enhancem ent between 
urinary bladder cancer and  other tis­
sues has already decreased (Fig 7). 
Thus according to the findings in 
this study, use of a fast imaging tech­
nique—at least one image acquired 
every 2 seconds—at the beginning of 
enhancement provides the best infor­
mation to help differentiate malignant 
from benign lesions. Findings on im­
ages that depict maximal SI informa­
tion are less reliable. Kim et al (15) 
also demonstrated that staging based 
on images obtained after 20 seconds 
was more often correct than  staging 
based on images obtained later. The 
images obtained at 20 seconds are ob­
tained before the plateau phase; at 20 
seconds the differences in SI between 
urinary bladder cancer and  nonmalig- 
nant structures are still greater than  is 
depicted on images obtained in the 
plateau phase (Fig 7).
Determination of the slope value 
did not allow reliable recognition of 
malignant lesions. This finding con­
flicts w ith that of Verstraete at al, w ho 
found slope images to be of value in 
distinguishing benign from malignant 
lesions (19), The difference betw een 
their results and ours m aybe explained 
by the heterogeneous distribution of 
the slope values for bladder cancer, 
which made differentiation difficult. 
Moreover, Verstraete et al used para­
metric images w ith  a fat suppression 
factor instead of color-coded images (19).
The beginning of enhancem ent 
can be quantitatively determ ined on  
the basis of time images just by look­
ing at the color. Therefore, there was 
no in ter observer variability in assess­
m ent of the start of lesion enhance­
ment. At fast dynamic MR imaging, 
urinary bladder cancers show ed early 
enhancem ent 6.5 seconds after the 
beginning of arterial enhancem ent, 
which in most patients occurred 4
in 61 Tumors
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seconds earlier than in surrounding 
normal organs or postbiopsy tissue. 
With use of a turbo FLASH technique 
that applied a threshold of 10 seconds 
after the beginning of arterial enhance­
ment, the accuracy for differentiation 
of postbiopsy effects from tumor im­
proved from 79% to 90%, and the 
specificity increased from 33% to 92%. 
These results are in agreement with 
other reported data (18,19) that show 
imaging in the first-pass phase, with 
at least one image acquired every 2 
seconds, has a higher specificity in the 
distinction of a benign from a malig­
nant lesion. Caution should be exer­
cised, however, because early enhance­
ment may occasionally occur in benign 
lesions that contain abundant hyper- 
vascular granulation tissue or in  pros­
tatitis, and it may occur in other ma­
lignant tissue such as prostate cancer. 
False-negative findings m aybe  seen 
in small tumors w ithout considerable 
neovascularization, as was the case in 
two of our patients in whom a thin 
layer of superficial tumor did not show 
early enhancement.
Tanimoto et al (26) also found that 
fast dynamic imaging improved stag­
ing accuracy. They found an 85% ac­
curacy w ith  fast SE imaging w ith one 
image acquired every 7 seconds, a 
74% accuracy w ith delayed enhance­
m ent imaging, and a 58% accuracy 
w ith unenhanced imaging. In their 
study, however, only patients with­
out previous TUR were included, so 
no information was obtained about 
staging after TUR. Our technique dif­
fers from theirs in  several ways: The 
sequence we used is six times faster 
than the sequence they used, our per­
ception of minimal differences in en-
Table 3
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hancement was increased by our use 
of subtraction and time images, and 
finally the turbo FLASH sequence we 
used is highly sensitive for minimal 
contrast enhancement (27). As en­
hancement differences are minimal 
between tumor and tissue after TUR, 
imaging with a sequence with a 7-sec- 
ond time resolution is expected to be 
less effective than imaging with the 
turbo FLASH technique we used.
Our overall accuracy in tumor stag­
ing improved significantly, from 67% 
to 84% (P < .01, McNemar test), owing 
to improved differentiation between 
postbiopsy effect and urinary bladder 
cancer and to better depiction of ex- 
travesical tumor extension. Further-
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a. b.
Figure 6. Transition cell carcinoma, stage T4a, on right side, with normal-size lymph node 
containing metastasis on left side, (a) Tl-weighted MP-RAGE image shows tumor (long ar­
rows) and normal-size (11 x 6 X 6 mm) lymph node (short arrows), (b) Time image shows 
equal early enhancement of bladder tumor (long arrows) and node (short arrow) at 6.25 sec­
onds after the start of arterial enhancement. Findings at histologic examination confirmed 
normal-size metastatic lymph node, a = artery, v -  vein.
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Figure 7. Time (i)-to-SI (Signal) curve shows different enhance­
ment patterns of regions of interest of various tissues and the im­
portance of fast imaging in the early first-pass phase. Every image 
represents 1.25 second. At time t„, the arterial enhancement above 
the noise threshold starts to become visible, followed shortly by 
urinary bladder carcinoma (ca) at time tca, parametrium (pm) at time 
tpw/ and bladder wall (wall) at time tw. The difference in 51 between 
urinary bladder carcinoma and parametrium is highest in the first- 
pass phase. At 45 seconds, in the equilibrium phase, most struc­
tures have reached their maximal SI. The difference between uri­
nary bladder carcinoma and parametrium is less prominent at this 
time. a.u. = arbitrary units.
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more, interobserver variation was only 
5%. The overall accuracy for tum or 
staging on the basis of unenhanced 
images in this study (67%) is low com­
pared with accuracies reported by
other authors (69%-93%) (2-16,22).
This may be explained by the fact that
all of our patients were examined 1-4 
weeks after TUR or biopsy. In all other 
studies, MR imaging was not performed 
within 4 weeks after TUR or biopsy. 
We found no differences in staging 
early (1 week) versus later (4 weeks) 
after TUR; therefore, our technique
can be used  1 w eek after TUR. We 
obtained high-re solution T2-weighted 
images, b u t results w ith unenhanced 
MR images m ight have been better if 
w e h ad  used  thinner, 4-5-mm-thick 
sections w ithou t an  intersection gap.
The FLASH sequence may be of 
value in the assessment of lym ph 
node metastases. At CT, lym ph node 
metastases w ere reported to enhance 
(28). Likewise, in  our study, enhance­
m ent of metastatic nodes was also 
seen at MR imaging. All metastatic 
nodes that w ere depicted at turbo 
FLASH imaging show ed enhance­
m ent as early or even slightly earlier 
than  the bladder tumor. Earlier en­
hancem ent was explained by a higher 
grade of malignancy in one patient 
(Fig 1). In two patients, this technique 
w as sensitive enough to depict metas­
tases in normal-size (11 X 6 x  5-mm) 
nodes. To our knowledge, this has not 
been  reported  to have occurred with 
any  noninvasive imaging modality 
before. Because the turbo FLASH se­
quence is a single-section technique, 
its ability to depict normal-size lym ph 
nodes is not truly assessed. A majority 
of normal-size lymph nodes are not 
imaged in this single-section examina­
tion. Nevertheless, in six patients the 
turbo FLASH single-section technique 
correctly depicted late or no node en­
hancem ent in normal-size nodes with­
out metastases. In one patient w ith an 
enlarged node and  in one patient with 
a normal-size node w ithout metasta­
ses, however, early enhancem ent was 
found. The value of this technique for 
depicting node metastases in normal- 
size nodes, therefore, necessitates fur­
ther investigation. The combination of 
the three-dimensional MP-RAGE and  
dynamic technique has a high accu­
racy (93%) in the staging of lym ph  
nodes in  this study. Therefore, this 
technique can help select patients for 
lym ph node biopsy prior to p lanned 
cystectomy. Note, however, that the 
difference in accuracy for node stag­
ing betw een unenhanced  and en­
hanced images was not statistically 
significant.
A major limitation of the present 
technique is that it can be perform ed 
in  only a single section, with m oder­
ate resolution (128 x 256 matrix) and 
signal-to-noise ratio. In two patients, 
the section level was incorrect. Be­
cause b ladder cancer can "crawl" su­
perficially along the bladder wall an d  
invade at different sites, it is possible 
to pick the w rong  level on the basis of 
the three-dimensional data set. In an ­
other patient, microscopic residual 
tum or was not depicted. In most p a ­
tients, tum or and  normal-size nodes
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Figure 8. Stage T4b transition cell carcinoma before and after chemotherapy, (a) O n  time image obtained before chem otherapy ,  tum or (ar­
rows) in b ladder  d ivert icu lum  starts to enhance  2.5 seconds after the start of arterial e n h a n c e m e n t  (b) Fast spin-echo T2-weighted image ob­
tained after chem otherapy  show s res idual  wall th ickening (solid arrows) and  residual low-SI area in perivesical fat (open arrows), which are 
evidence of stage T3a o r  T3b malignancy, (c) On time image obtained after chem otherapy, b ladder wall th ickening starts to enhance  12.5 sec­
onds after the start of arterial e n h a n c e m e n t  (short arrows). LoW'SI area shows two foci of early en h an cem en t  (long arrows). The u nenh an ced  
images (not shown) revealed tha t  these foci represen t  vessels a n d  not tumor. On time images, arteries are always depic ted  as m uch  larger, ow­
ing to pulsation artifacts (visible in  Figs lc  an d  6b). Findings a t  his to log ic  examination (not shown) confirmed absence of malignancy.
could not both be included in the 
FLASH section. The results of our 
study, however, show that use of fast 
techniques, even in a single section, 
results in better differentiation be­
tween postbiopsy tissue and tumor 
and in improved staging. N ew  ultra­
fast multisection dynamic techniques 
with a higher resolution will have to 
be developed to enable multisection 
fast dynamic MR imaging during the 
first-pass phase of contrast enhance­
ment, With these techniques, the en­
tire tumor volume could be delineated 
with a high specificity.
Although the differentiation b e­
tween postbiopsy tissue and urinary 
bladder cancer at turbo FLASH time 
imaging is better than at imaging with 
existing techniques, the present limi­
tations of this sequence do not justify 
obviating cystectomy in patients with­
out early lesion enhancement. On the 
other hand, on the basis of better rec­
ognition of extravesical tumor exten­
sion and lymph node metastases with 
this technique, a more appropriate 
treatment decision can be made be­
tween curative cystectomy and pallia­
tive or neoadjuvant chemotherapy.
The behavior of urinary bladder 
cancer after intravenous injection of a 
gadolinium-containing contrast agent, 
as documented on fast dynamic MR 
images and time images, is a reflec­
tion of its neovascularity. Microvessel 
quantification is reported to be an in­
dependent predictor of survival in 
patients w ith invasive bladder cancer 
and might be useful to help select pa­
tients w ho w ould benefit from adju­
vant therapy (24,25), Perhaps fast dy­
namic contrast-enhanced MR imaging 
could be used to help select and fol­
low-up patients who undergo neoad­
juvant chemotherapy. Initial results 
with this technique in the follow-up 
of patients after chemotherapy are 
promising (Fig 8), but further pro­
spective studies are needed.
We conclude that fast dynamic con­
trast-enhanced turbo FLASH imaging 
with at least one image acquired every
2 seconds results in improved detec­
tion and staging of urinary bladder 
cancer. Time images that display the 
beginning of enhancement in relation 
to arterial enhancement permit more 
accurate differentiation between post­
biopsy effects and tumor, which re­
sults in improved tumor staging in 
patients within 4 weeks after TUR or 
biopsy. Additionally, this technique 
may help detect metastases in normal- 
sized nodes. Currently, however, this 
technique cannot be performed in mul­
tiple sections. Therefore, new ultrafast 
multisection dynamic techniques need 
to be developed to enable imaging of 
the entire tumor volume and all re­
gional lymph node areas. ■
»
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